Nyxoah SA (NYXH)
1.605
-0.04
(-2.13%)
USD |
NASDAQ |
Aug 26, 16:00
1.605
0.00 (0.00%)
After-Hours: 18:46
Nyxoah EPS Diluted (Quarterly) : -0.6723 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.6723 |
| March 31, 2026 | -0.4315 |
| December 31, 2025 | -0.6821 |
| September 30, 2025 | -0.7359 |
| June 30, 2025 | -0.624 |
| March 31, 2025 | -0.6294 |
| December 31, 2024 | -0.4941 |
| September 30, 2024 | -0.545 |
| June 30, 2024 | -0.4596 |
| March 31, 2024 | -0.4506 |
| December 31, 2023 | -0.4085 |
| Date | Value |
|---|---|
| September 30, 2023 | -0.2889 |
| June 30, 2023 | -0.4868 |
| March 31, 2023 | -0.4938 |
| December 31, 2022 | -0.5247 |
| September 30, 2022 | -0.2431 |
| June 30, 2022 | -0.2056 |
| March 31, 2022 | -0.2943 |
| September 30, 2021 | -0.4099 |
| June 30, 2021 | -0.3774 |
| March 31, 2021 | -0.309 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ion Beam Applications SA | -- |
| Accuray, Inc. | -0.0154 |
| Medtronic Plc | 0.9649 |
| Orthofix Medical, Inc. | -0.3862 |
| ResMed, Inc. | 2.645 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -38.33M |
| Revenue (Quarterly) | 8.924M |
| Total Expenses (Quarterly) | 47.25M |
| Enterprise Value | 120.91M |
| Gross Profit Margin (Quarterly) | 36.12% |
| Profit Margin (Quarterly) | -429.5% |
| Earnings Yield | -157.1% |
| Normalized Earnings Yield | -154.61 |